DNA Script Announces World’s First Enzymatic Synthesis of a High-Purity 150-Nucleotide Strand of DNA

DNA Script’s approach achieves parity with conventional chemical synthesis — and is poised to quickly surpass the current gold standard in speed, efficacy and length for commercial DNA synthesis. October 02, 2018 01:40 PM Pacific Daylight Time SAN FRANCISCO, Calif.–(BUSINESS WIRE)–DNA Script, the global leader in the development of enzymatic DNA synthesis, today announced that... Read more

DNA Script Raises €11 Million ($13 Million) in Series A Financing Led by Illumina Ventures to Advance Development of Its DNA Synthesis Technology

September 12, 2017 06:00 AM Pacific Daylight Time PARIS–(BUSINESS WIRE)–Synthetic DNA manufacturer DNA Script has today announced a Series A fundraising of 11 million euros ($13 million) led by Illumina Ventures with additional investments from M Ventures, the corporate venture arm of Merck KGaA, Darmstadt, Germany, plus existing investors Sofinnova Partners, Kurma Partners, and Idinvest... Read more